Researchers engineered a portable CRISPR-based assay for mpox detection designed for field use following the 2025 outbreak in Sierra Leone. The work, led by Gopal, Abay, and Payne, aims to improve on-site diagnosis and support quicker epidemic containment decisions. The approach focuses on adapting CRISPR diagnostics for rapid deployment outside centralized laboratories, reflecting urgent demand for scalable outbreak detection tools. Portability also matters for logistics in resource-constrained settings where sample transport can slow confirmation. The publication adds to the expanding CRISPR diagnostics pipeline, where next steps typically include validation across diverse specimen types and real-world workflows.